AstraZeneca got favorable verdict in first Seroquel Trial
Written by Jack Taylor
AstraZeneca landed a favorable verdict in the first Seroquel Lawsuit to go to the trial. It is the only Seroquel trial till date as AstraZeneca decided to settle other Seroquel litigations out of the court or with court ordered mediation. The New Jersey state court jury concluded in this trial that the AstraZeneca Plc, the manufacturer of Seroquel had sufficiently warned the doctor treating the patient about the risks of severe side effects caused by use of this drug.
Seroquel is an oral drug containing quetiapine as main active ingredient. It is used for treatment of Schizophrenia in adults or children older tha
13 years. It is also used for treatment of bipolar disorder or manic depression in children above 10 years and adults. It is also used with other antidepressant drugs. Doctors prescribe it for other purposes as well. It was introduced for treatment of Schizophrenia in the market in 1997.
The use of Seroquel has been associated with hyperglycemia and diabetes in patients using this drug. Many studies also revealed the same fact. Reports about its association with these side effects started coming in since this drug came into circulation. FDA too issued safety alerts and warnings related to this drug.
AstraZeneca was also blamed of promoting its antipsychotic drug Seroquel for off label uses. FDA warned it for providing misleading and false information about the drug. It was also found guilty of paying kickbacks to doctors for prescribing Seroquel for off label uses. It had to pay $520 million to U.S. Department of Justice to settle the lawsuit alleging it of paying kickbacks and off label promotion filed by U.S. Department of Justice. The Justice Department blamed AstraZeneca to market this drug for treatment of aggression, Alzheimer’s disease, anxiety, depression and post-traumatic stress disorder (PTSD). All these are off label uses of the drug.
The first Seroquel lawsuit to go for trial was a product liability case and was one of the cases in the mass tort involving thousands of cases. The case was Baker Vs. AstraZeneca. Most of the cases against AstraZeneca related to Seroquel side effects have been consolidated in an MDL by the Judicial Panel on Multi district Litigation. This MDL or Multi District Litigation was pending in the Middle District of Florida. There were other consolidate groups of cases pending in other areas including Delaware, New Jersey, and New York.
The plaintiff in above lawsuit alleged that he developed diabetes as a side effect of using Seroquel. The jury issued a defense verdict, as it was not proved that plaintiff’s condition was a result of Seroquel use. The evidence suggested that the plaintiff had many pre-existing risk factors. He was already at risk of developing diabetes. He also ignored the warning on the drug’s label. Hence his condition could not be attributed to use of Seroquel, the antipsychotic drug manufactured by AstraZeneca. Thus jury issued a verdict in favor of AstraZeneca Plc.
Even though AstraZeneca got a favorable verdict in first Seroquel trial, it went for settlement in other Seroquel lawsuits.
For More Information Visit: http://www.unsafedrugs.com/3077/astrazeneca-favorable-verdict-seroquel-trial
Article author
About the Author
About Author: Jack Taylor Powers Taylor LLP is a boutique litigation firm that represents people injured by unsafe drugs. The attorneys of Powers Taylor founded this firm to focus on client needs. We employ unique and creative litigation strategies to obtain decisive results for our clients.
Further reading
Further Reading
Article
Turn Extra Test Strips Into Cash: HMH Med Buyback Expands Nationwide Program
A Growing Challenge in Diabetes Care Across the country, millions of people living with diabetes rely on test strips and other supplies to monitor their health. These items are essential, but they often accumulate in households for various reasons. Sometimes prescriptions change, sometimes people switch to different brands, and sometimes supplies arrive in larger quantities than needed. What was once a lifeline can quickly become a drawer full of unused materials. The Problem
February 17, 2026
Article
Why Doctors Prefer AI-Powered Medical Scribes Over Manual Documentation
Long clinic days often spill into late nights, leaving physicians buried under hours of unfinished documentation. Instead of focusing on patients, much of your time disappears into typing, charting, and catching up on notes. Itâs no surprise that administrative overload has become one of the biggest drivers of physician burnout today. This is where AI medical scribes come in. By automating clinical documentation in real time, they give healthcare providers the freedom to fo
September 9, 2025
Article
Your First Root Canal Treatment: What to Expect and How to Prepare
If youâre scheduled for your first root canal treatment, you might be feeling a mix of anxiety and relief. Anxiety about what to expect during the procedure, and relief that youâre on your way to alleviating discomfort caused by a tooth infection or decay. Hereâs a comprehensive guide to help you understand the root canal process, what you can expect, and how best to prepare for it. Understanding Root Canal TreatmentrnA root canal is a dental procedure designed to clear
February 21, 2025
Article
Why Malpractice Insurance is Essential for Anesthesiologists: An Overview of Costs and Benefits
The role of an anesthesiologist is critical in modern medicine, serving as the guardian of patient safety during surgical procedures. With this immense responsibility comes the necessity of having robust malpractice insurance . For anesthesiologists, the implications of malpractice claims can be profound, making understanding the associated costs and benefits of malpractice insurance essential. Understanding Malpractice Insurance Malpractice insurance is a specific type of pr
February 7, 2025